Rapid Response™ COVID-19 Antigen Rapid Test Device
The Rapid Response™ COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens. It is designed to analyze nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. The test is also suitable for individuals without symptoms or other epidemiological reasons to suspect COVID-19 infection, especially when tested twice over two (or three) days with at least 24 hours (and no more than 36 hours) between tests. This test is authorized for use at the Point of Care, i.e., in patient care settings. The product is available in both 5 tests per kit and 25 tests per kit sizes.